Biocartis Financial Statements From 2010 to 2024
| BCART Stock | EUR 0.29 0.00 0.00% |
Check Biocartis Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biocartis Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biocartis financial statements analysis is a perfect complement when working with Biocartis Group Valuation or Volatility modules.
Biocartis |
Biocartis Group NV Company Operating Margin Analysis
Biocartis Group's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biocartis Group Operating Margin | (0.85) % |
Most of Biocartis Group's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biocartis Group NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Biocartis Group NV has an Operating Margin of -0.8461%. This is 97.59% lower than that of the Health Care Equipment & Supplies sector and 98.66% lower than that of the Health Care industry. The operating margin for all Belgium stocks is 84.64% lower than that of the firm.
Biocartis Group NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biocartis Group's current stock value. Our valuation model uses many indicators to compare Biocartis Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biocartis Group competition to find correlations between indicators driving Biocartis Group's intrinsic value. More Info.Biocartis Group NV is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biocartis Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biocartis Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biocartis Group Financial Statements
Biocartis Group stakeholders use historical fundamental indicators, such as Biocartis Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biocartis Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biocartis Group's assets and liabilities are reflected in the revenues and expenses on Biocartis Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biocartis Group NV. Please read more on our technical analysis and fundamental analysis pages.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people.
Pair Trading with Biocartis Group
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocartis Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will appreciate offsetting losses from the drop in the long position's value.Moving against Biocartis Stock
The ability to find closely correlated positions to Biocartis Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocartis Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocartis Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocartis Group NV to buy it.
The correlation of Biocartis Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocartis Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocartis Group NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocartis Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.